Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the ER - a Double-blind Randomized Prospective Study

Trial Profile

Sublingual Versus Endovenous Fentanyl for Pain Treatment in Trauma Patients in the ER - a Double-blind Randomized Prospective Study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 25 Apr 2018

At a glance

  • Drugs Fentanyl (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Apr 2018 Planned End Date changed from 1 Jan 2018 to 1 Aug 2018.
    • 19 Apr 2018 Status changed from recruiting to active, no longer recruiting.
    • 17 Mar 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top